Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Werner

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Transplantation Proceedings|June 19, 2001
Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label studyD R Snydman, M E Falagas, R Avery, et al.
Annals of Internal Medicine|August 1, 1985
Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccinationB G Werner, J L Dienstag, B J Kuter, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonatesD R Snydman, B G Werner, H C Meissner, et al.
American Journal of Epidemiology|November 1, 1984
A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccinationD R Snydman, A Muñoz, B G Werner, et al.
Annals of Internal Medicine|July 1, 1984
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacyJ L Dienstag, B G Werner, B F Polk, et al.
JAMA|August 23, 1985
Absence of antibodies to HTLV-III in health workers after hepatitis B vaccinationJ L Dienstag, B G Werner, M F McLane, et al.
Annals of Internal Medicine|September 1, 1986
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typingsD E Craven, Z L Awdeh, L M Kunches, et al.
Transplantation Proceedings|December 1, 1988
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trialD R Snydman, B G Werner, N L Tilney, et al.
Transplantation Proceedings|February 11, 1991
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trialsD R Snydman, B G Werner, N L Tilney, et al.
The New England Journal of Medicine|October 22, 1987
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipientsD R Snydman, B G Werner, B Heinze-Lacey, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|June 19, 2001
Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label studyD R Snydman, M E Falagas, R Avery, et al.
Annals of Internal Medicine|August 1, 1985
Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccinationB G Werner, J L Dienstag, B J Kuter, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonatesD R Snydman, B G Werner, H C Meissner, et al.
American Journal of Epidemiology|November 1, 1984
A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccinationD R Snydman, A Muñoz, B G Werner, et al.
Annals of Internal Medicine|July 1, 1984
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacyJ L Dienstag, B G Werner, B F Polk, et al.
JAMA|August 23, 1985
Absence of antibodies to HTLV-III in health workers after hepatitis B vaccinationJ L Dienstag, B G Werner, M F McLane, et al.
Annals of Internal Medicine|September 1, 1986
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typingsD E Craven, Z L Awdeh, L M Kunches, et al.
Transplantation Proceedings|December 1, 1988
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trialD R Snydman, B G Werner, N L Tilney, et al.
Transplantation Proceedings|February 11, 1991
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trialsD R Snydman, B G Werner, N L Tilney, et al.
The New England Journal of Medicine|October 22, 1987
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipientsD R Snydman, B G Werner, B Heinze-Lacey, et al.
Pageof 6